IL-12 is not required for induction of type 1 cytokine responses in viral infections

Journal of Immunology

Volumn 162, Issue 2, 1999, Pages 965-973

  Oxenius, Annette ^a,b   Karrer, Urs ^a   Zinkernagel, Rolf M ^a   Hengartner, Hans ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 12;

ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CYTOKINE PRODUCTION; HELPER CELL; HOST RESISTANCE; INFECTION RESISTANCE; LISTERIA MONOCYTOGENES; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VACCINIA VIRUS; VESICULAR STOMATITIS VIRUS; VIRUS EXPRESSION;

ANIMALS; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; IMMUNOGLOBULIN G; INTERLEUKIN-12; KILLER CELLS, NATURAL; LISTERIA INFECTIONS; LYMPHOCYTE ACTIVATION; LYMPHOCYTIC CHORIOMENINGITIS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; TH1 CELLS; VESICULAR STOMATITIS-INDIANA VIRUS; VIRUS REPLICATION;

EID: 0033556145     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Magram, J., S. E. Connaughton, R. R. Warrier, D. M. Carvajal, C.-y. Wu, J. Ferrante, C. Stewart, U. Sarmiento, D. A. Fahery, and M. K. Gately. 1996. IL-12-deficient mice are defective in IFN-γ production and type 1 cytokine responses. Immunity 4:471.
2. Cooper, A. M., J. Magram, J. Ferrante, and I. M. Orme. 1997. Interleukin 12 (IL-12) is crucial to the development of protective immunity to mice intravenously infected with Mycobacterium tuberculosis. J. Exp. Med. 186:39.
3. Mattner, F., J. Magram, J Ferrante, P. Launois, K. Di Padova, R. Behin, M. K. Gately, and G. Alber. 1996. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 response. Eur. J. Immunol. 26:1553.
4. McIntyre, K. W., D. J. Shuster, K. M. Gillooly, R. R. Warrier, S. E. Connaughton, L. B. Hall, L. H. Arp, M. K. Gately, and J. Magram. 1996. Reduced incidence and severity of collagen-induced arthritis in interleukin-12-deficient mice. Eur. J. Immunol. 26:2933.
5. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547.
6. Gazzinelli, R. T., M. Wysocka, S. Hayashi, E. J. Denkers, S. Hieny, P. Caspar, G. Trichieri, and A. Sher. 1994. Parasite-induced IL-12 stimulates early IFN-γ synthesis and resistence during acute infection with Toxoplasma gondii. J. Immunol. 153:2533.
7. Sypek, J. P., C. L. Chung, E. H. Mayor, J. M. Subramanyam, S. J. Goldman, D. S. Sieburth, S. F. Wolf, and R. G. Schaub. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797.
8. Tripp, C. S., S. F. Wolf, and E. R. Unanue. 1993. Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc. Natl. Acad. Sci. USA 90:3725.
9. Scharton-Kersten, T. M., L. C. C. Afonso, M. Wysocka, G. Trinchieri, and P. Scott. 1995. Interleukin 12 is required for natural killer cell activation and subsequent T helper 1 cell development in experimental leishmaniasis. J. Immunol. 154:5320.
10. Kamanaka, M., P. Yu, T. Yasui, K. Yoshida, T. Kawabe, T. Horii, T. Kisimoto, and H. Kikutani. 1996. Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity. Immunity 4:275.
11. Campbell, K. A., P. J. Ovendale, M. K. Kennedy, W. C. Fanslow, S. G. Reed, and C. R. Maliszewski. 1996. CD40 ligand is required for protective cell-mediated immunity to Leishmania major. Immunity 4:283.
12. + T cell functions. J. Exp. Med. 183:2209.
13. + T cells correlating with cytotoxic activity in vitro are more efficient in antivaccinia virus protection than CD4-dependent interleukins. J. Immunol. 146:4301.
14. Bancroft, G. J., R. D. Schreiber, and E. R. Unanue. 1991. Natural immunity: a T cell independent pathway of macrphage activation defined in scid mice. Immunol. Rev. 124:5.
15. Fehr, T., G. Schoedon, B. Odermatt, T. Holtschke, M. Schneemann, M. F. Bachmann, T. W. M. Mak, I. Horak, and R. M. Zinkernagel. 1997. Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis. J. Exp. Med. 185:921.
16. + T cell mediated protection against an intracellular bacterium by perforin-dependent cytotoxicity. Eur. J. Immunol. 24:3068.
17. Mackett, M., T. Yilma, J. K. Rose, and B. Moss. 1985. Vaccinia virus recombinants: expression of VSV genes and protective immunization of mice and cattle. Science 227:433.
18. Whitton J. L., I. R. Gebhard, H. Lewicki, A. Tishon, and M. B. Oldstone. 1988. Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus. J. Virol. 62:687.
19. Battegay, M., D. Moskophidis, H. Waldner, M. A. Bründler, Fung, W. P. Leung, T. W. Mak, H. Hengartner, and R. M. Zinkernagel. 1993. Impairment and delay of neutralizing antiviral antibody responses by virus specific cytotoxic T cells. J. Immunol. 151:5408.
20. Matsuura, Y., R. D. Possee, H. A. Overton, and D. H. L. Bishop. 1987. Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J. Gen. Virol. 68:1233.
21. Oxenius, A., M. F. Bachmann, P. G. Ashton-Rickardt, S. Tonegawa, R. M. Zinkernagel, and H. Hengartner. 1995. Presentation of endogenous viral proteins in association with major histocompatibility complex II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system. Eur. J. Immunol. 25:3402.
22. Oxenius, A., M. F. Bachmann, R. M. Zinkernagel, and H. Hengartner. 1998. Virus-specific MHC class II-restricted TCR transgenic mice: implicatios of elevated Th cell frequencies on humoral and cellular immune responses after viral infection. Eur. J. Immunol. 28:390.
23. + T cells specific for a pancreatic β cell neo-antigen. Immunity 2:563.
24. Roost, H. P., S. Charan, and R. M. Zinkernagel. 1990. Analysis of the kinetics of antiviral memory T help in vivo: characterization of short lived cross-reactive T help. Eur. J. Immunol. 20:2547.
25. Scott, D. W., and R. K. Gershon. 1970. Determination of total and mercapto-ethanol-resistant antibody in the serum sample. Clin. Exp. Immunol. 6:13.
26. Zinkernagel, R. M., T. P. Leist, H. Hengartner, and A. Althage. 1985. Susceptibility to lymphocytic choriomeningitis virus isolates correlates directly with early and high cytotoxic T cell activity, as well as with footpad swelling reaction, and all three are regulated by H-2D. J. Exp. Med. 162:2125.
27. Battegay, M, S. Cooper, A. Althage, J. Baenziger, H. Hengartner and R. M. Zinkernagel. 1991. Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24 or 96 well plates. J. Virol. Methods 33:191.
28. Tanaka, T., F. Kitamura, Y. Nagasaka, K. Kuida, H. Suwa, and M. Miyasaka. 1993. Selective long-term elimination of natural killer cells in vivo by anti-interleukin 2 receptor β chain monoclonal antibody in mice. J. Exp. Med. 178:1103.
29. Ehl, S., R. Neusch, T. Tanaka, M. Myasaka, H. Hengartner, and R. M. Zinkernagel. 1996. A comparison of efficacy and specificity of three NK depleting antibodies. J. Immunol. Methods 199:149.
30. Leist, T. P., M. Eppler, and R. M. Zinkernagel. 1989. Enhanced virus replication and inhibition of lymphocytic choriomeningitis virus disease in anti-IFN γ-treated mice. J. Virol. 63:2813.
31. Schijns, V. E. C. J., B. L. Haagmans, C. M. H. Wierda, B. Kruithof, I. A. F. M. Heijnen, G. Alber, and M. C. Horzinek. 1998. Mice lacking IL-12 develop polarized Th1 cells during viral infection. J. Immunol. 160:3958.
32. Bachmann, M. F., H. Hengartner, and R. M. Zinkernagel. 1995. T. helper cells-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction. Eur. J. Immunol. 25:3445.
33. Ramsay, A. J., J. Ruby, and I. A. Ramshaw. 1993. The case for cytokines as effector molecules in the resolution of virus infection. Immunol. Today 14:155.
34. Ramshaw, I., J. Ruby, A. Ramsay, G. Ada, and G. Karupiah. 1992. Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infecions in vivo. Immunol. Rev. 127:157.
35. Kündig, T., I. Castelmur, M. F. Bachmann, D. Abraham, D. Binder, H. Hengartner, and R. M. Zinkernagel. 1993. Fewer protective cytotoxic T cell epitopes than T helper cell epitopes on vesicular stomatitis virus. J. Virol. 67:3680.
36. Kägi, D., P. Seiler, J. Pavlovic, B. Ledermann, K. Bürki, R. M. Zinkernagel, and H. Hengartner. 1995. The roles of perforin- and fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25:2356.
37. Orange, J. S., and C. A. Biron. 1996. An absolute and restricted requirement for IL-12 in natural killer cell IFN-γ production and antiviral defense. J. Immunol. 156:1138.
38. Kaufmann, S. H. E. 1993. Immunity to intracellular bacteria. Annu. Rev. Immunol. 11:129.
39. Bancroft, G. J., R. D. Schreiber, G. C. Bosma, M. J. Bosma, and E. R. Unanue. 1987. A T cell-independent mechanism of macrophage activation by interferon-γ. J. Immunol. 139:1104.
40. Flesch, I. E., J. H. Hess, S. Huang, M. Aguet, J. Rothe, H. Bluethmann, and S. H. Kaufmann. 1995. Early interleukin 12 production by macrophages in response to mycobacterial infection depends on interferon γ and tumor necrosis factor α. J. Exp. Med. 181:1615.
41. Heufler, C., F. Koch, U. Stanzl, G. Topar, M. Wysocka, G. Trinchieri, A. Enk, R. M. Steinmann, N. Romani and G. Schuler. 1996. Interleukin-12 is produced by dendritic cells and mediated T helper 1 development as well as interferon-γ production by T helper 1 cells. Eur. J. Immunol. 26:659.
42. Ma, X., J. M. Chow, G. Gri, G. Carra, F. Gerosa, S. F. Wolf, R. Dzialo, and G. Trinchieri. 1996. The interleukin 12 p40 gene promoter is primed by interferon γ in monocytic cells. J. Exp. Med. 183:147.
43. Trichieri, G. 1997. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-I2, IFN-γ). Curr. Opin. Immunol. 9:17.
44. Orange, J. S., and C. A. Biron. 1996. Characterization of IL-12, IFN-αβ, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J. Immunol. 156:4746.
45. Gallimore, A., A. Glithero, A. Godkin, A. C. Tissot, A. Plückthun, T. Elliott, H. Hengartner, and R. M. Zinkernagel. 1998. Induction and exhaustion of lymphocytic choriomeningitis virus-specific cytotoxic T lymphocytes visualized using soluble terameric major histocompatibility complex class-I peptide complexes. J. Exp. Med. 187:1383.
46. Biron, C. A., H. A. Young, and M. T. Kasaian. 1990. Interleukin 2-induced proliferation of murine natural killer cells in vivo. J. Exp. Med. 171:173.
47. Belardelli, F. and I. Gresser. 1996. The neglected role of type 1 interferon in the T-cell response: implications for its clinical use. Immunol. Today 17:369.
48. Wenner, C. A., M. L. Güler, S. E. Macatonia, A. O'Garra, and K. M. Murphy. 1996. Roles of IFN-γ and IFN-α in IL12-induced T helper cell development. 7. Immunol. 156:1442.
49. Cousens, L. P., J. S. Orange, H. C. Su, and C. A. Biron. 1997. Interferon-α/β inhibition of interleukin-12 and interferon-γ production in vivo and endogenously during viral infection. Proc. Natl. Acad. Sci. USA 94:634.
50. Lohoff, M., D. Ferrick, H. W. Mittrücker, G. S. Duncan, S. Bischof, M. Rollinghöff, and T. Mak. 1997. Interferon regulatory factor-I is required for a T helper 1 immune response in vivo. Immunity 6:681.
51. Okamura, H., T. Tsutsi, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, K. et al. 1995. Cloning of a new cytokine that induces IFN-γ production by T cells. Nature 378-88.
52. Szabo, S. J., A. S. Dighe, U. Gubler, and K. M. Murphy. 1997. Regulation of the interleukin (IL)-12Rβ 2 subunit expression in developing T helper 1 (Th1) and Th2 cells. J. Exp. Med. 195:817.
53. Swain, S. L., A. D. Weinberg, M. English, and G. Huston. 1990. IL-4 and IFN-γ direct the development of distinct subsets of helper T cells. Fed. Proc. 4:2020.
54. Scott, P. 1991. IFN-γ modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147:3149.
55. Chatelain, R., K. Varkila, and R. L. Coffman. 1992. IL-4 induces a Th2 response in Leishmania major-infected mice. J. Immunol. 148:1182.
56. + T cells. Int. Immunol. 5:877.
57. Portnoy, D. A., R. D. Schreiber, P. Connelly, and L. G. Tilney. 1989. γ-Interferon limits access of listeria monocylogenes to the macrophage cytoplasm. J. Exp. Med. 170:2141.